AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 100 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2014 | $4,086,000 | – | 211,167 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,650,000 | $48,893,000 | 3.10% |
Voce Capital Management LLC | 110,789 | $2,044,000 | 2.72% |
Palo Alto Investors LP | 3,441,233 | $63,491,000 | 2.67% |
FALCON POINT CAPITAL, LLC | 839,477 | $13,180,000 | 1.91% |
EII CAPITAL MANAGEMENT, INC. | 119,690 | $2,208,000 | 0.83% |
CLARK ESTATES INC/NY | 163,300 | $3,013,000 | 0.50% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 38,358 | $708,000 | 0.50% |
Jabre Capital Partners S.A. | 120,000 | $2,214,000 | 0.43% |
Credit Capital Investments LLC | 15,000 | $277,000 | 0.31% |
Alambic Investment Management, L.P. | 151,442 | $2,794,000 | 0.30% |